Study: Lithium microdosing may benefit patients in later stages of Alzheimer's disease
According to Claudio Cuello of the Department of Pharmacology and Therapeutics at “They stimulated us to continue working with this approach on a more advanced pathology,” Cuello, who also led that earlier study, said. As detailed in the Journal of Alzheimer’s Disease, Cuello’s research team administered the same microdose used in the earlier study to transgenic rats at the equivalent of late preclinical stages of Alzheimer’s disease in humans. At this post-plaque stage, the research team said, the beta-amyloid had already accumulated to such an extent that it had started to affec...
Source: naturalnews.com